投资者关系活动 类别 特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他（请文字说明其他活动内容） 参与单位名称及 人员姓名 国海证券 万鹏辉 时间 2025 年 5 月 15 日(周四)上午 10:00-11:00 地点 公司会议室 上市公司接待人 员姓名 1、金凯生科董事长兼总裁 FUMIN WANG（王富民）先生； 2、金凯生科董事会秘书兼财务总监王琦先生。 投资者关系活动 主要内容介绍 一、参观公司阜新生产基地 二、投资者问答交流 问题 1、公司 2025 年一季度业绩大幅增长，主要原因是什 么？2025 年二季度及全年的业绩预计情况如何？ 回复：2024 年度，公司通过强化全面服务能力、构建综合 协同能力、加强特色反应能力等能力建设、加大研发投入、加强 BD 队伍建设、拓展新服务市场与客户、开拓技术服务新业务领 域、收缩资本开支等努力，加之当期订单集中交付等因素，公司 在 2025 年一季度业绩大幅回升。 同时，因宏观环境、行业发展、贸易政策等多重不确定性因 素影响，以及客户订单交付周期波动，公司未来业绩也存在波动 的风险，敬请投资者注意相关风险。 关 ...

金凯（辽宁）生命科技股份有限公司 2024 年度持续督导跟踪报告 | 保荐人名称：中信建投证券股份有限公司 | 上市公司简称：金凯生科 | | --- | --- | | 保荐代表人姓名：逯金才 | 联系电话：010-5605 2488 | | 保荐代表人姓名：张林 | 联系电话：010-5605 1430 | 一、保荐工作概述 中信建投证券股份有限公司关于 三、公司及股东承诺事项履行情况 | 公司及股东承诺事项 | 是否履行承诺 | 未履行承诺的原因及解决措施 | | --- | --- | --- | | 首次公开发行时所做的承诺 | 是 | 不适用 | 四、其他事项 | 报告事项 | 说明 | | --- | --- | | 1.保荐代表人变更及其理由 | 不适用 | | 2.报告期内中国证监会和本所对保荐人或者其保 | （1）2024 年 1 月，中信建投证券因 | | 荐的公司采取监管措施的事项及整改情况 | 在保荐芯天下 IPO 项目过程中，未对发 | | | 行人所处市场情况及同行业可比公司 | | | 情况予以充分关注并核查发行人对终 | | | 端客户的销售情况，对发行人业绩预计 | | | ...

截至5月13日收盘，阿尔茨海默概念上涨1.74%，位居概念板块涨幅第5，板块内，24股上涨，华大基 因、迪安诊断、美年健康等涨幅居前，分别上涨14.55%、8.27%、6.72%。跌幅居前的有*ST双成、金凯 生科、联影医疗等，分别下跌4.96%、1.15%、0.80%。 今日涨跌幅居前的概念板块 | 代码 | 简称 | 今日涨跌幅 | 今日换手率 | 主力资金流量（万 | 主力资金净流入比率 | | --- | --- | --- | --- | --- | --- | | | | （%） | （%） | 元） | （%） | | 300676 | 华大基 因 | 14.55 | 5.13 | 12606.52 | 10.91 | | 000766 | 通化金 马 | 4.09 | 4.77 | 7912.36 | 9.04 | | 600789 | 鲁抗医 药 | 2.26 | 11.15 | 6213.39 | 5.96 | | 688068 | 热景生 物 | 2.40 | 3.98 | 3651.30 | 9.40 | | 002044 | 美年健 康 | 6.72 | 5.71 | 3326.88 ...

A股出海概念延续近期强势，服装、家居方向领涨，盛泰集团、皮阿诺、华纺股份、浙江正特、迎丰股 份涨停，美之高、太湖雪双双涨超20%，恒泰照明、有棵树、致欧科技、赛维时代涨超10%。 ...

Core Viewpoint - The overseas concept continues to show strong performance, particularly in the apparel and home furnishing sectors, with several stocks reaching their daily limit up [1] Group 1: Stock Performance - Sheng Tai Group, Pi'ano, Huafang Co., Zhejiang Zhengte, and Yingfeng Co. all hit the daily limit up [1] - Meizhi Gao and Taihu Xue both surged over 20% [1] - Hengtai Lighting, Youkeshu, Zhiou Technology, and Saiwei Times all increased by more than 10% [1]

Market Overview - The Shanghai Composite Index is at 3305.11 points, above the annual line, with an increase of 0.80% [1] - The total trading volume of A-shares is 646.819 billion yuan [1] Stocks Breaking Annual Line - A total of 233 A-shares have surpassed the annual line today [1] - Notable stocks with significant deviation rates include: - Jinkai Biological Science and Technology (10.11%) - Disen Power (9.84%) - Hanbo High-tech (8.84%) [1] Stock Performance Details - The top stocks with their respective performance metrics are as follows: - Jinkai Biological: Price increased by 10.32%, turnover rate 13.55%, latest price 33.02 yuan [1] - Disen Power: Price increased by 10.04%, turnover rate 1.77%, latest price 4.93 yuan [1] - Hanbo High-tech: Price increased by 9.42%, turnover rate 3.54%, latest price 15.33 yuan [1] - Other notable stocks include: - Jiashitang (9.97%, 3.57%, 13.13 yuan) - Sanmu Group (9.94%, 7.78%, 3.54 yuan) [1] Additional Stocks with Minor Deviations - Stocks with smaller deviation rates that have just crossed the annual line include: - Yongqing Environmental Protection - Dongjian Technology - Aishide [1]

Group 1: Financial Performance - In 2024, the company achieved a revenue of 497.01 million yuan and a net profit of 38.61 million yuan, both showing a significant decline year-on-year [6][7] - In Q1 2025, the company reported a revenue of 176.34 million yuan and a net profit of 47.42 million yuan, indicating a substantial recovery due to prior adjustments and concentrated order deliveries [7] Group 2: Strategic Adjustments - The company has made strategic adjustments in response to adverse international trade policies, enhancing service capabilities and increasing R&D investments [2][3] - To mitigate risks from U.S. tariff policies, the company plans to upgrade its production base in Wisconsin, USA, by expanding capacity and improving service capabilities [3][10] Group 3: Environmental Commitment - In 2024, the company invested 41.50 million yuan in environmental protection, purchasing 14,925,000 kWh of green electricity, resulting in a reduction of CO2 emissions by 13,013,107.50 kg [4][5] Group 4: Market Outlook and Risks - The company acknowledges uncertainties in overseas business due to tariff policies, which may affect order acquisition and delivery cycles [5][8] - The global pharmaceutical market is expected to continue growing, with increasing demand for CDMO services, presenting potential growth opportunities for the company [8][13] Group 5: Shareholder Relations - The company emphasizes its commitment to protecting shareholder interests and will disclose any significant shareholding changes in accordance with regulations [8][13] - A cash dividend of 4 yuan per 10 shares is proposed for 2024, amounting to 48.18 million yuan, which exceeds the net profit for that year [13]

Summary of Key Points Core Viewpoint - The latest financing balance of the ChiNext market is 336.92 billion yuan, showing a decrease of 0.7 billion yuan compared to the previous period, with 19 stocks experiencing a financing balance growth of over 10% and 12 stocks seeing a decline of over 10% [1]. Financing Balance Overview - As of April 24, the ChiNext index fell by 0.68%, with a total margin balance of 337.83 billion yuan, down by 0.7 billion yuan from the previous trading day. The financing balance specifically is 336.92 billion yuan, a decrease of 0.7 billion yuan, while the securities lending balance is 91.3 million yuan, down by 3.22 million yuan [1]. - A total of 417 stocks saw an increase in financing balance, with 19 stocks increasing by more than 10%. The largest increase was observed in Changhua Chemical, with a financing balance of 54.14 million yuan, up by 29.08% [1][3]. Stocks with Increased Financing Balance - The stocks with significant financing balance increases include: - Changhua Chemical: 54.14 million yuan, +29.08%, closing price 19.90 yuan, +1.38% [3]. - Zhonghuan Hailu: 71.04 million yuan, +23.90%, closing price 21.61 yuan, -5.67% [3]. - Weihai De: 92.84 million yuan, +23.53%, closing price 29.20 yuan, -4.58% [3]. - The average increase for stocks with over 10% growth was 1.85%, with notable performers including Jinkai Biotechnology, Zhaomin Technology, and Haitai Technology, with increases of 16.88%, 14.03%, and 6.96% respectively [1][3]. Stocks with Decreased Financing Balance - A total of 520 stocks experienced a decrease in financing balance, with 12 stocks declining by more than 10%. The largest decrease was seen in Pulaide, with a financing balance of 19.71 million yuan, down by 24.07% [4]. - Other notable declines include: - Jingang Photovoltaic: 33.29 million yuan, -23.39% [4]. - Tianyuan Pet: 68.45 million yuan, -19.54% [4]. Capital Flow Insights - On April 24, among the stocks with increased financing balance, 12 stocks saw net inflows of main funds, with Jinkai Biotechnology leading at 137 million yuan, followed by Jinyang Co. at 66.30 million yuan and Shengyuan Environmental Protection at 32.23 million yuan [2]. - Conversely, 7 stocks experienced net outflows, with Zhaomin Technology leading at 129 million yuan, followed by New Aluminum Era at 74.46 million yuan and Hengbo Co. at 61.49 million yuan [2].

业务评价：公司去年的ROIC为1.51%，资本回报率不强。去年的净利率为7.77%，算上全部成本后，公 司产品或服务的附加值一般。 偿债能力：公司现金资产非常健康。 融资分红：公司上市2年以来，累计融资总额12.17亿元，累计分红总额6882.67万元，分红融资比为 0.06。 据证券之星公开数据整理，近期金凯生科（301509）发布2025年一季报。截至本报告期末，公司营业总 收入1.76亿元，同比上升41.83%，归母净利润4741.78万元，同比上升183.24%。按单季度数据看，第一 季度营业总收入1.76亿元，同比上升41.83%，第一季度归母净利润4741.78万元，同比上升183.24%。本 报告期金凯生科应收账款上升，应收账款同比增幅达77.94%。 本次财报公布的各项数据指标表现尚佳。其中，毛利率51.09%，同比增29.69%，净利率26.89%，同比 增99.7%，销售费用、管理费用、财务费用总计3054.26万元，三费占营收比17.32%，同比减19.29%，每 股净资产18.24元，同比减28.33%，每股经营性现金流0.38元，同比减55.7%，每股收益0.39元，同比增 105. ...

分行业看，今日换手率超20%的个股中，所属基础化工行业个股最多，有6只个股上榜；计算机、汽车 等紧随其后，分别有5只、4只个股上榜。 交易所公开信息显示，今日高换手率创业板股共有8只上榜龙虎榜，买卖居前营业部中，有7股出现机构 身影，恒勃股份有3家机构专用席位上榜，合计净买入3462.25万元，新铝时代有2家机构专用席位上 榜，合计净买入2005.85万元，金凯生科有1家机构专用席位上榜，合计净买入977.19万元，新瀚新材有3 家机构专用席位上榜，合计净买入936.57万元，久祺股份有4家机构专用席位上榜，合计净买入479.44万 元，深股通现身1股龙虎榜，新铝时代获深股通净买入1302.83万元，营业部净买入居前的有天元宠物、 新瀚新材、金凯生科，净买入金额分别为7329.19万元、5686.28万元、3666.89万元，营业部净卖出居前 的是恒勃股份、新铝时代、新天地，净卖出金额分别为6573.16万元、3634.01万元、489.75万元。 资金流向方面，高换手率个股中，有11股今日获主力资金净流入，净流入金额较多的有金凯生科、飞天 诚信、新瀚新材，净流入金额分别为1.37亿元、9893.16万元、9 ...